The T cell receptor (TCR) on CD8+ T cells binds to the MHC-I compound on tumor cells, resulting in the production of cytolytic factors (e.g., perforin and granzyme) and inflammatory cytokines (e.g., IL-2 and IL-12) that directly kill tumor cells (15). Here, CD8A is linked to neoplasm.